scholarly journals Large-Bore Aspiration Thrombectomy: Catalyst for a Revolution in Treating Pulmonary Embolism

2021 ◽  
Vol 48 (5) ◽  
Author(s):  
Thomas M. Tu
Circulation ◽  
2015 ◽  
Vol 132 (suppl_3) ◽  
Author(s):  
Navkaranbir S Bajaj ◽  
Rajat Kalra ◽  
Sameer Ather ◽  
Jason Guichard ◽  
William J Lancaster ◽  
...  

Background: Catheter-based treatments (CBTs) are diverse set of techniques aimed at relieving pulmonary arterial obstruction in patients with high-risk pulmonary embolism. Multiple modalities are currently available. The mortality and safety outcomes have not been studied among these different modalities. Hypothesis: We conducted this investigation to determine the mortality and safety of individual modalities. Methods: We searched SCOPUS since inception to November 2014 using predefined criteria. Studies including massive PE or a combination of massive and submassive PE, as defined by the American Heart Association, were included. In-hospital mortality rates and pooled safety complication rate (defined as a composite of peri- and post-procedural cardiac arrest, minor access site bleeding, major access site bleeding, and bleeding at other sites) were estimated using standard meta-analytic methods and compared among six different groups namely aspiration thrombectomy, intrapulmonary thrombolysis (IP), mechanical fragmentation (MF), rheolytic thrombectomy (RT), ultrasound-accelerated thrombolysis (USAT) and multiple simultaneous modalities. Results: In 54 eligible studies with 1,333 patients, 1,357 CBT procedures were performed. Patients undergoing USAT had the lowest in-hospital mortality rate whereas patients undergoing RT had the highest in-hospital mortality rate (p = 0.011, Table). Intrapulmonary thrombolysis had the highest pooled rate of safety outcome whereas MF had the lowest rate among various techniques (p = 0.034, Table). Conclusion: There is significant heterogeneity in mortality and safety outcomes between various CBT modalities. Our analysis is limited by variance in study quality and baseline characteristics. More investigation is required to determine the optimal type of CBT for high-risk PE.


2019 ◽  
Vol 15 (4) ◽  
pp. 497-498 ◽  
Author(s):  
Aleksander Araszkiewicz ◽  
Stanisław Jankiewicz ◽  
Sylwia Sławek-Szmyt ◽  
Aneta Klotzka ◽  
Marek Grygier ◽  
...  

2018 ◽  
pp. 1381-1381 ◽  
Author(s):  
Marek Roik ◽  
Dominik Wretowski ◽  
Michał Machowski ◽  
Michał Ciurzyński ◽  
Marcin Krakowian ◽  
...  

2020 ◽  
Vol 15 (10) ◽  
pp. 1764-1768
Author(s):  
Julian Pohlan ◽  
Sarah Nadine Kamel ◽  
Giovanni Federico Torsello ◽  
Daniel Zickler ◽  
Jan Matthias Kruse ◽  
...  

2021 ◽  
Vol 39 ◽  
Author(s):  
Andy Sohn ◽  
◽  
James Hu ◽  
Jennifer Colnick ◽  
Justin George ◽  
...  

Pulmonary embolism can occur following dislodgement of deep venous thrombosis into the pulmonary artery circulation, which results in obstruction of the pulmonary artery system and can be fatal. The consequences of pulmonary embolism include hypotension, right heart strain, and hypoxia. In the long term, pulmonary embolism may lead to Chronic Thromboembolic Pulmonary Hypertension (CTEPH). Patients who develop hypotensive massive and submassive pulmonary embolism can be treated with large-bore aspiration thrombectomy. In the acute setting, this improves short-term outcomes by decreasing the ICU stay. It can also reduce the risk of CTEPH. Options for large-bore aspiration thrombectomy include the FlowTriever™ system (Inari Medical, Irvine, CA) and the Lightning 12 vascular thrombectomy system (Penumbra Inc., Alameda, CA). This review discusses the pathophysiology of pulmonary embolism, management, and options for large-bore aspiration thrombectomy.


2020 ◽  
Vol 37 (01) ◽  
pp. 062-073
Author(s):  
William Bremer ◽  
Charles E. Ray ◽  
Ketan Y. Shah

AbstractPulmonary embolism is a common cause of morbidity and mortality which continues to increase in overall incidence. Because it can occur with a wide range of clinical presentations, different guidelines have been developed for appropriate risk stratification of patients; interventional radiology plays a vital role in the management of both massive and submassive pulmonary embolism. Catheter-directed therapy, including mechanical and aspiration thrombectomy, standard catheter-directed thrombolysis, and ultrasound-accelerated thrombolysis, has many benefits, including lower thrombolytic doses and intraclot administration of thrombolytic therapy. While the role of catheter-directed therapy is still being developed, four important prospective studies have demonstrated its safety and efficacy. Additional studies comparing short- and long-term clinical outcomes in patients treated with catheter-directed therapy versus anticoagulation are the next step in understanding its role within the management of submassive pulmonary embolism. Furthermore, multidisciplinary pulmonary embolism response teams, in which interventional radiology plays a crucial role, are becoming essential to appropriately managing pulmonary embolism patients, including selection of those who may benefit from catheter-directed therapy.


2018 ◽  
Vol 29 (1) ◽  
pp. 101-106 ◽  
Author(s):  
Juan José Ciampi-Dopazo ◽  
Juan María Romeu-Prieto ◽  
Marcelino Sánchez-Casado ◽  
Beatriz Romerosa ◽  
Alfonso Canabal ◽  
...  

2015 ◽  
Vol 24 (1) ◽  
pp. 46-54 ◽  
Author(s):  
Hulya Bayiz ◽  
Mert Dumantepe ◽  
Burak Teymen ◽  
Ibrahim Uyar

CHEST Journal ◽  
2021 ◽  
Vol 160 (4) ◽  
pp. A2009-A2010
Author(s):  
vinit singh ◽  
Rana Prathap Padappayil ◽  
Ali Jaffery ◽  
DHAIRYA GOR ◽  
Patrick Lee

Sign in / Sign up

Export Citation Format

Share Document